Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
F7 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Ltb4r1 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Pygl - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Laptm5 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Arsi - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Gm2a - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Hoxa3 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Adap2 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Slc37a2 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Plek - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Selp - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Cd84 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Gm14548 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Ccr2 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Prkg1 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Fgr - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Fcrla - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on